Randomized Double-Blind Controlled Study on the Safety and Efficacy of a Novel Injectable Cross-linked Hyaluronic Gel for the Correction of Moderate-to-Severe Nasolabial Wrinkles

• Published in: Aesthetic plastic surgery 2019-04, Vol.43 (2), p.470-479
• Main Authors: Fino, Pasquale, Toscani, Marco, Grippaudo, Francesca Romana, Giordan, Nicola, Scuderi, Nicolò
• Format: Article
• Language: English
• Subjects: Acids; Adult; Botulinum toxin; Cosmetic Techniques; Dermal Fillers; Dermatology; Double-Blind Method; Double-blind studies; Female; Gels; Humans; Hyaluronic acid; Hyaluronic Acid - administration & dosage; Hyaluronic Acid - adverse effects; Injections; Longitudinal studies; Male; Medicine; Medicine & Public Health; Middle Aged; Nasolabial Fold; Original Article; Otorhinolaryngology; Plastic Surgery; Skin; Skin Aging; Treatment Outcome; Ultrasonic imaging; Viscoelasticity
• ISSN: 0364-216X; 1432-5241
• DOI: 10.1007/s00266-018-1284-x

Introduction The current study compares two hyaluronic acid fillers, Ial System Duo and Belotero Basic/Balance, for the treatment of wrinkles. Materials and Methods This is a single-center, double-blind randomized controlled study. Inclusion criteria consisted of subjects with bilateral nasolabial wrinkles. Each subject was treated with both products: One was applied on the right side and the other on the left side of the face. The quantity of product injected and any problems or local reactions (erythema, edema, pain or itching) were recorded and reassessed at 3 and 6 months and then monthly until complete absorption of the product. The Wrinkle Severity Rating Scale (WSRS) and the Global Aesthetic Improvement Scale (GAIS) were used for the assessment, as well as an ultrasound measurement of the skin thickness. Results Complete data were available for 59 subjects. At 3 and 6 months, both products showed improvement in the WSRS and GAIS score in the areas treated compared to pre-treatment assessments, although no significant differences were observed between them. No resulting significant differences were observed on skin thickness among the two products, which were completely reabsorbed in 285 ± 34 days (Ial System Duo) and 277 ± 34 days (Belotero Basic/Balance; Student’s t test: p  = 0.2181). No significant differences were observed with regard to the subject’s satisfaction and adverse events. Conclusions The Ial System Duo achieves long-term permanence (more than 9 months confirmed by ultrasound) in correction of moderate and severe wrinkles, similar to Belotero Basic/Balance. Both products showed a high safety profile and a high degree of subject and physician satisfaction. Level of Evidence II This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266 .